Warnecke-Eberz U - Search Results

1

Novel diagnostic and prognostic biomarkers in esophageal cancer.

Plum PS, Bollschweiler E, Hölscher AH, Warnecke-Eberz U. Plum PS, et al. Expert Opin Med Diagn. 2013 Nov;7(6):557-71. doi: 10.1517/17530059.2013.843526. Epub 2013 Oct 4. Expert Opin Med Diagn. 2013. PMID: 24093836 Review.

2

ERCC1: impact in multimodality treatment of upper gastrointestinal cancer.

Metzger R, Bollschweiler E, Hölscher AH, Warnecke-Eberz U. Metzger R, et al. Future Oncol. 2010 Nov;6(11):1735-49. doi: 10.2217/fon.10.140. Future Oncol. 2010. PMID: 21142660 Review.

3

Impact of ABCB1 C3435T polymorphism on lymph node regression in multimodality treatment of locally advanced esophageal cancer.

Narumiya K, Metzger R, Bollschweiler E, Alakus H, Brabender J, Drebber U, Hölscher AH, Warnecke-Eberz U. Narumiya K, et al. Pharmacogenomics. 2011 Feb;12(2):205-14. doi: 10.2217/pgs.10.174. Pharmacogenomics. 2011. PMID: 21332314

4

Exosomal onco-miRs from serum of patients with adenocarcinoma of the esophagus: comparison of miRNA profiles of exosomes and matching tumor.

Warnecke-Eberz U, Chon SH, Hölscher AH, Drebber U, Bollschweiler E. Warnecke-Eberz U, et al. Tumour Biol. 2015 Jun;36(6):4643-53. doi: 10.1007/s13277-015-3112-0. Epub 2015 Jan 29. Tumour Biol. 2015. PMID: 25631748

5

Molecular markers predicting lymph node metastasis in early esophageal cancer.

Plum PS, Warnecke-Eberz U, Dhaouadi O, Alakus H, Drebber U, Metzger R, Prenzel KL, Hölscher AH, Bollschweiler E. Plum PS, et al. Histol Histopathol. 2015 Oct;30(10):1193-202. doi: 10.14670/HH-11-618. Epub 2015 Apr 14. Histol Histopathol. 2015. PMID: 25869644

6

Both GLUT-1 and GLUT-14 are Independent Prognostic Factors in Gastric Adenocarcinoma.

Berlth F, Mönig S, Pinther B, Grimminger P, Maus M, Schlösser H, Plum P, Warnecke-Eberz U, Harismendy O, Drebber U, Bollschweiler E, Hölscher A, Alakus H. Berlth F, et al. Among authors: warnecke eberz u. Ann Surg Oncol. 2015 Dec;22 Suppl 3:S822-31. doi: 10.1245/s10434-015-4730-x. Epub 2015 Jul 17. Ann Surg Oncol. 2015. PMID: 26183839

7

Diagnostic marker signature for esophageal cancer from transcriptome analysis.

Warnecke-Eberz U, Metzger R, Hölscher AH, Drebber U, Bollschweiler E. Warnecke-Eberz U, et al. Tumour Biol. 2016 May;37(5):6349-58. doi: 10.1007/s13277-015-4400-4. Epub 2015 Dec 2. Tumour Biol. 2016. PMID: 26631031

8

Molecular Markers for the Prediction of Minor Response to Neoadjuvant Chemoradiation in Esophageal Cancer: Results of the Prospective Cologne Esophageal Response Prediction (CERP) Study.

Bollschweiler E, Hölscher AH, Herbold T, Metzger R, Alakus H, Schmidt H, Drebber U, Warnecke-Eberz U. Bollschweiler E, et al. Among authors: warnecke eberz u. Ann Surg. 2016 Nov;264(5):839-846. doi: 10.1097/SLA.0000000000001911. Ann Surg. 2016. PMID: 27741011 Free article.

9

Neoadjuvant chemoradiation changes podoplanin expression in esophageal cancer patients.

Warnecke-Eberz U, Plum P, Schweinsberg V, Drebber U, Bruns CJ, Müller DT, Hölscher AH, Bollschweiler E. Warnecke-Eberz U, et al. World J Gastroenterol. 2020 Jun 21;26(23):3236-3248. doi: 10.3748/wjg.v26.i23.3236. World J Gastroenterol. 2020. PMID: 32684738 Free PMC article.

10

Molecular biology of esophageal cancer.

Metzger R, Schneider PM, Warnecke-Eberz U, Brabender J, Hölscher AH. Metzger R, et al. Onkologie. 2004 Apr;27(2):200-6. doi: 10.1159/000076913. Onkologie. 2004. PMID: 15138356

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

47 results

Search Page